PCR Diagnostics

FDA-cleared respiratory panel providing 95% sensitivity and 99% specificity for rapid identification of respiratory pathogens and antibiotic resistance.

PCR Diagnostics Laboratory
95%
Sensitivity
99%
Specificity

Advanced Respiratory Testing

Our FDA-cleared respiratory panel provides an overall sensitivity of 95% and specificity of 99%. Rapid and accurate diagnostic testing for respiratory pathogens helps identify which patients to isolate and determines appropriate antibiotic or antiviral therapy.

With the increasing prevalence of antibiotic-resistant organisms and the critical need for appropriate antimicrobial stewardship, accurate and rapid respiratory pathogen identification has never been more important for optimal patient care and infection control.

Key Benefits of PCR Diagnostics

FDA-cleared respiratory testing provides significant advantages for patient care

High Accuracy

95% sensitivity and 99% specificity provide reliable results for confident clinical decision-making.

Rapid Results

Fast turnaround time enables quick isolation decisions and appropriate therapy initiation.

Resistance Detection

Identifies antibiotic resistance markers to guide appropriate antimicrobial therapy selection.

Comprehensive Panel

Detects multiple bacterial and viral respiratory pathogens in a single test.

Infection Control

Rapid pathogen identification supports effective isolation and infection control measures.

Antibiotic Stewardship

Supports responsible antibiotic use and reduces unnecessary antimicrobial exposure.

Clinical Applications

PCR diagnostics provides valuable insights across multiple healthcare settings

Emergency Medicine

  • • Acute respiratory illness
  • • Pneumonia diagnosis
  • • Sepsis evaluation
  • • Rapid triage decisions

Critical Care

  • • Ventilator-associated pneumonia
  • • ICU infection control
  • • Immunocompromised patients
  • • Outbreak investigation

Outpatient Care

  • • Primary care practices
  • • Urgent care centers
  • • Pediatric clinics
  • • Long-term care facilities

Implications of Antibiotic Resistance

2M

People acquire serious bacterial infections that are resistant to one or more prescribed antibiotics annually in the US

23K

People die as a direct result of antibiotic resistant infections each year

55%

Of antibiotic prescriptions for Acute Respiratory Tract Infections are unnecessary

Key Impacts of Antibiotic Resistance:

  • Increases mortality and morbidity from untreatable diseases
  • Increases risk of global spread of pathogens
  • Results in longer, more frequent hospital stays
  • Limits drug options at a time when pharmaceutical companies are developing fewer new antimicrobials
  • Increases cost of research for new drugs

The misuse of antibiotics costs the US healthcare system over $20 billion each year.

Comprehensive Pathogen Detection

Our multiplex PCR respiratory panel detects bacterial and viral respiratory pathogens

Bacterial Pathogens

  • • Bordetella parapertussis
  • • Bordetella pertussis
  • • Chlamydophila pneumoniae
  • • Haemophilus influenzae
  • • Klebsiella pneumoniae
  • • Legionella pneumophila
  • • Moraxella catarrhalis
  • • Mycoplasma pneumoniae
  • • Staphylococcus aureus
  • • Streptococcus pneumoniae
  • • Streptococcus pyogenes

Viral Pathogens

  • • Adenovirus
  • • Coronavirus 229E
  • • Coronavirus HKU1
  • • Coronavirus NL63
  • • Coronavirus OC43
  • • COVID-19
  • • Enterovirus
  • • Human bocavirus
  • • Human metapneumovirus (hMPV)
  • • Human Parainfluenza 1
  • • Human parainfluenza 2
  • • Human parainfluenza 3
  • • Human parainfluenza 4
  • • Human rhinovirus
  • • Influenza A
  • • Influenza B
  • • RSV AB

Reflexive Respiratory Antibiotic Resistance

  • • MecA, MecB, MecC

Testing Process

1

Sample Collection

Nasopharyngeal swab or respiratory specimen

2

PCR Analysis

Multiplex real-time PCR detection

3

Expert Review

Clinical interpretation and recommendations

4

Results Delivery

Rapid electronic reporting

References:

8- CDC. Antibiotic Resistance Threats in the United States, 2013.

9- Steinman MA et al. JAMA. 2003;289(6):719-725. Predictors of Broad-Spectrum Antibiotic Prescribing for Acute Respiratory Tract Infections in Adult Primary Care

10- Alliance for Prudent Use of Antibiotics; Cost of antibiotic resistance to U.S. families and the health care system.

Ready to Order PCR Testing?

Get accurate respiratory pathogen identification with our FDA-cleared testing panel.